Cargando…
Use of biological markers and pharmacokinetics in human health risk assessment.
There are two reasons to connect discussions of biological markers and pharmacokinetics. First, both tend to open up the black box between exposure and effect. Doing this promises more complete scientific understanding than simple input-output analysis, the possibility of better mechanism-based proj...
Autor principal: | Hattis, D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1519499/ https://www.ncbi.nlm.nih.gov/pubmed/2050066 |
Ejemplares similares
-
The challenge of mechanism-based modeling in risk assessment for neurobehavioral end points.
por: Hattis, D
Publicado: (1996) -
Assessing Cumulative Health Risks from Exposure to Environmental Mixtures—Three Fundamental Questions
por: Sexton, Ken, et al.
Publicado: (2007) -
Human health risks due to consumption of chemically contaminated fishery products.
por: Ahmed, F E, et al.
Publicado: (1993) -
Addressing Human Variability in Next-Generation Human Health Risk Assessments of Environmental Chemicals
por: Zeise, Lauren, et al.
Publicado: (2012) -
Risk assessment for neurobehavioral toxicity: SGOMSEC joint report.
por: Hattis, D, et al.
Publicado: (1996)